JG

James Gale

Chairman at BionPharma

Mr. Gale is the founding partner of Signet Healthcare Partners. He initiates investments and provides active management oversight to a number of portfolio companies. He is currently the Chairman of the Board of Alpex Pharma S.A. and Pfenex Inc., and also serves on the Board of Directors of Arbor Pharmaceutical, Spepharm AG, Paladin Laboratories, IGI, Inc., and Anteis SA. Prior to founding Signet Healthcare Partners, Mr. Gale was head of principal investment activities and head of investment banking for Gruntal & Co., LLC. While at Gruntal, Mr. Gale's investment activities included Andrx Corporation, Royce Laboratories (merged with Watson Pharmaceuticals), Lifecell Corporation, Neurocrine Biosciences, and BML Pharmaceuticals (acquired by Endo Pharmaceuticals). Prior to joining Gruntal, he originated and managed private equity investments for the Home Insurance Co., Gruntal's parent. Earlier in his career, Mr. Gale was a senior investment banker at E.F. Hutton & Co. Mr. Gale received his Masters of Business Administration from the University of Chicago.

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams